Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 6/20 | 0.59 |
| ▸ | CSNK2A2 | P19784 | 5/20 | 0.59 |
| ▸ | CSNK2B | P67870 | 5/20 | 0.59 |
| ▸ | PIM1 | P11309 | 14/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7517663 | 0.75 | MAPK1 (0.41) | — | |
| SCHEMBL7792227 | 0.75 | LMNA (0.36) | — | |
| SCHEMBL7792996 | 0.75 | CSNK2A2 (0.41) | CSNK2A1CSNK2A2CSNK2B | |
| SCHEMBL1759675 | 0.74 | CSNK2A1 (1.00) | CSNK2A1CSNK2A2CSNK2BPIM1 | |
| Hydrochloric Acid SCHEMBL7792147 | 0.74 | MAPK1 (0.40) | — | |
| SCHEMBL7789099 | 0.72 | KDR (0.39) | — | |
| SCHEMBL7789092 | 0.72 | MAPK1 (0.39) | — | |
| SCHEMBL7792159 | 0.72 | KDR (0.39) | — | |
| SCHEMBL7792153 | 0.72 | MAPK1 (0.39) | — | |
| SCHEMBL7793948 | 0.71 | KDR (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010047021-A1 | Cancer treatment | THE PROCTER & GAMBLE COMPANY | 2001-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010047021-A1 | Cancer treatment | MUSK, ALK, BCOR | CSNK2A1 598/4885CSNK2A2 891/4885CSNK2B 857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.